Liangliang Dai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Tissue Engineering

Signaling Pathway

Top Venues

Nature communications

Small (Weinheim an der Bergstrasse, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Siyu Meng, Huiping Du, Xiang Li, Xinmin Zheng, Pan Zhao, Zhang Yuan, Shaohui Huang, Rongjun Zhao, Liangliang Dai
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells. ACS nano 18 (4) (2024)
Siyu Meng, Huiping Du, Xiang Li, Xinmin Zheng, Pan Zhao, Zhang Yuan, Shaohui Huang, Rongjun Zhao, Liangliang Dai
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells. ACS nano (2024)
Siyu Meng, Huiping Du, Xiang Li, Xinmin Zheng, Pan Zhao, Zhang Yuan, Shaohui Huang, Rongjun Zhao, Liangliang Dai
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells. ACS nano 18 (4) (2024)
Huiping Du, Siyu Meng, Meijuan Geng, Pan Zhao, Liyang Gong, Xinmin Zheng, Xiang Li, Zhang Yuan, Hui Yang, Rongjun Zhao, Liangliang Dai
Detachable MOF-Based Core/Shell Nanoreactor for Cancer Dual-Starvation Therapy With Reversing Glucose and Glutamine Metabolisms. Small (Weinheim an der Bergstrasse, Germany) (2023)
Liangliang Dai, Mengjiao Yao, Zhenxiang Fu, Xiang Li, Xinmin Zheng, Siyu Meng, Zhang Yuan, Kaiyong Cai, Hui Yang, Rongjun Zhao
Multifunctional metal-organic framework-based nanoreactor for starvation/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy. Nature communications 13 (1) (2022)
Xinmin Zheng, Pan Zhang, Zhenxiang Fu, Siyu Meng, Liangliang Dai, Hui Yang
Applications of nanomaterials in tissue engineering. RSC advances 11 (31) (2021)